カテゴリー： LP Information, 世界, 医療/バイオ

世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場予測 2023年-2029年

◆英語タイトル：Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU5129）◆商品コード：LP23JU5129
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：98
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場」は、過去の販売実績から2022年の世界の非アルコール性脂肪肝炎（NASH）バイオマーカーの総販売量を検討し、2023年から2029年の予測される非アルコール性脂肪肝炎（NASH）バイオマーカーの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非アルコール性脂肪肝炎（NASH）バイオマーカーの市場規模を掲載し、XXX百万米ドル規模の世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場の詳細な分析を提供します。本インサイトレポートは、世界の非アルコール性脂肪肝炎（NASH）バイオマーカー業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場における各社の独自のポジションをより深く理解するために、非アルコール性脂肪肝炎（NASH）バイオマーカー製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非アルコール性脂肪肝炎（NASH）バイオマーカーの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非アルコール性脂肪肝炎（NASH）バイオマーカーの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非アルコール性脂肪肝炎（NASH）バイオマーカーのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非アルコール性脂肪肝炎（NASH）バイオマーカーの世界主要メーカーとしては、Biopredictive、 Quest Diagnostics、 Exalenz Bioscience、 GENFIT、 Siemens Healthineers、 ONE WAY LIVER、 Prometheus Laboratories、 Gilead Sciencesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非アルコール性脂肪肝炎（NASH）バイオマーカー市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非アルコール性脂肪肝炎（NASH）バイオマーカー市場をセグメンテーションし、種類別 (血清バイオマーカー、サイトケラチン-18（CK18）マーカー、炎症マーカー、その他)、用途別 (病院、診断センター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：血清バイオマーカー、サイトケラチン-18（CK18）マーカー、炎症マーカー、その他

・用途別区分：病院、診断センター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場の10年間の市場状況・展望は？
・世界および地域別に見た非アルコール性脂肪肝炎（NASH）バイオマーカー市場成長の要因は何か？
・非アルコール性脂肪肝炎（NASH）バイオマーカーの市場機会はエンドマーケットの規模によってどのように変化するのか？
・非アルコール性脂肪肝炎（NASH）バイオマーカーのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非アルコール性脂肪肝炎（NASH）バイオマーカーの年間販売量2018-2029、地域別現状・将来分析
・非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別セグメント：血清バイオマーカー、サイトケラチン-18（CK18）マーカー、炎症マーカー、その他
・非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別セグメント：病院、診断センター、その他
・非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場
・企業別のグローバル非アルコール性脂肪肝炎（NASH）バイオマーカー市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非アルコール性脂肪肝炎（NASH）バイオマーカーの年間売上：2018-2023年の売上、市場シェア
・企業別の非アルコール性脂肪肝炎（NASH）バイオマーカー販売価格
・主要企業の非アルコール性脂肪肝炎（NASH）バイオマーカー生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非アルコール性脂肪肝炎（NASH）バイオマーカーの地域別レビュー
・地域別の非アルコール性脂肪肝炎（NASH）バイオマーカー市場規模2018-2023：年間販売量、売上
・主要国別の非アルコール性脂肪肝炎（NASH）バイオマーカー市場規模2018-2023：年間販売量、売上
・南北アメリカの非アルコール性脂肪肝炎（NASH）バイオマーカー販売の成長
・アジア太平洋の非アルコール性脂肪肝炎（NASH）バイオマーカー販売の成長
・ヨーロッパの非アルコール性脂肪肝炎（NASH）バイオマーカー販売の成長
・中東・アフリカの非アルコール性脂肪肝炎（NASH）バイオマーカー販売の成長

南北アメリカ市場
・南北アメリカの国別の非アルコール性脂肪肝炎（NASH）バイオマーカー販売量、売上（2018-2023）
・南北アメリカの非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別販売量
・南北アメリカの非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非アルコール性脂肪肝炎（NASH）バイオマーカー販売量、売上（2018-2023）
・アジア太平洋の非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別販売量
・アジア太平洋の非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非アルコール性脂肪肝炎（NASH）バイオマーカー販売量、売上（2018-2023）
・ヨーロッパの非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別販売量
・ヨーロッパの非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非アルコール性脂肪肝炎（NASH）バイオマーカー販売量、売上（2018-2023）
・中東・アフリカの非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別販売量
・中東・アフリカの非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非アルコール性脂肪肝炎（NASH）バイオマーカーの製造コスト構造分析
・非アルコール性脂肪肝炎（NASH）バイオマーカーの製造プロセス分析
・非アルコール性脂肪肝炎（NASH）バイオマーカーの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非アルコール性脂肪肝炎（NASH）バイオマーカーの主要なグローバル販売業者
・非アルコール性脂肪肝炎（NASH）バイオマーカーの主要なグローバル顧客

地域別の非アルコール性脂肪肝炎（NASH）バイオマーカー市場予測レビュー
・地域別の非アルコール性脂肪肝炎（NASH）バイオマーカー市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非アルコール性脂肪肝炎（NASH）バイオマーカーの種類別市場規模予測
・非アルコール性脂肪肝炎（NASH）バイオマーカーの用途別市場規模予測

主要企業分析
Biopredictive、 Quest Diagnostics、 Exalenz Bioscience、 GENFIT、 Siemens Healthineers、 ONE WAY LIVER、 Prometheus Laboratories、 Gilead Sciences
・企業情報
・非アルコール性脂肪肝炎（NASH）バイオマーカー製品
・非アルコール性脂肪肝炎（NASH）バイオマーカー販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Forecast” looks at past sales and reviews total world Non-alcoholic Steatohepatitis (NASH) Biomarkers sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-alcoholic Steatohepatitis (NASH) Biomarkers sales for 2023 through 2029. With Non-alcoholic Steatohepatitis (NASH) Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-alcoholic Steatohepatitis (NASH) Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Non-alcoholic Steatohepatitis (NASH) Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-alcoholic Steatohepatitis (NASH) Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-alcoholic Steatohepatitis (NASH) Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-alcoholic Steatohepatitis (NASH) Biomarkers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-alcoholic Steatohepatitis (NASH) Biomarkers.
The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-alcoholic Steatohepatitis (NASH) Biomarkers players cover Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories and Gilead Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-alcoholic Steatohepatitis (NASH) Biomarkers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Serum Biomarkers
Cytokeratin-18 (CK 18) Marker
Inflammatory Markers
Others
Segmentation by application
Hospitals
Diagnostic Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Biopredictive
Quest Diagnostics
Exalenz Bioscience
GENFIT
Siemens Healthineers
ONE WAY LIVER
Prometheus Laboratories
Gilead Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market?
What factors are driving Non-alcoholic Steatohepatitis (NASH) Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-alcoholic Steatohepatitis (NASH) Biomarkers market opportunities vary by end market size?
How does Non-alcoholic Steatohepatitis (NASH) Biomarkers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-alcoholic Steatohepatitis (NASH) Biomarkers by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-alcoholic Steatohepatitis (NASH) Biomarkers by Country/Region, 2018, 2022 & 2029
2.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
2.2.1 Serum Biomarkers
2.2.2 Cytokeratin-18 (CK 18) Marker
2.2.3 Inflammatory Markers
2.2.4 Others
2.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type
2.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
2.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Type (2018-2023)
2.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Centers
2.4.3 Others
2.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application
2.5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Market Share by Application (2018-2023)
2.5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Application (2018-2023)
3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company
3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Breakdown Data by Company
3.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales by Company (2018-2023)
3.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2018-2023)
3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Revenue by Company (2018-2023)
3.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2018-2023)
3.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2018-2023)
3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Company
3.4 Key Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Location Distribution
3.4.2 Players Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-alcoholic Steatohepatitis (NASH) Biomarkers by Geographic Region
4.1 World Historic Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country/Region (2018-2023)
4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth
4.4 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth
4.5 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth
4.6 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth
5 Americas
5.1 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
5.1.1 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023)
5.1.2 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023)
5.2 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type
5.3 Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region
6.1.1 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2018-2023)
6.1.2 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2018-2023)
6.2 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type
6.3 APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers by Country
7.1.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023)
7.1.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023)
7.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type
7.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers by Country
8.1.1 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type
8.3 Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
10.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
10.4 Industry Chain Structure of Non-alcoholic Steatohepatitis (NASH) Biomarkers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors
11.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customer
12 World Forecast Review for Non-alcoholic Steatohepatitis (NASH) Biomarkers by Geographic Region
12.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Forecast by Region
12.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Forecast by Region (2024-2029)
12.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Forecast by Type
12.7 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Forecast by Application
13 Key Players Analysis
13.1 Biopredictive
13.1.1 Biopredictive Company Information
13.1.2 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biopredictive Main Business Overview
13.1.5 Biopredictive Latest Developments
13.2 Quest Diagnostics
13.2.1 Quest Diagnostics Company Information
13.2.2 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Quest Diagnostics Main Business Overview
13.2.5 Quest Diagnostics Latest Developments
13.3 Exalenz Bioscience
13.3.1 Exalenz Bioscience Company Information
13.3.2 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Exalenz Bioscience Main Business Overview
13.3.5 Exalenz Bioscience Latest Developments
13.4 GENFIT
13.4.1 GENFIT Company Information
13.4.2 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GENFIT Main Business Overview
13.4.5 GENFIT Latest Developments
13.5 Siemens Healthineers
13.5.1 Siemens Healthineers Company Information
13.5.2 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Siemens Healthineers Main Business Overview
13.5.5 Siemens Healthineers Latest Developments
13.6 ONE WAY LIVER
13.6.1 ONE WAY LIVER Company Information
13.6.2 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ONE WAY LIVER Main Business Overview
13.6.5 ONE WAY LIVER Latest Developments
13.7 Prometheus Laboratories
13.7.1 Prometheus Laboratories Company Information
13.7.2 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Prometheus Laboratories Main Business Overview
13.7.5 Prometheus Laboratories Latest Developments
13.8 Gilead Sciences
13.8.1 Gilead Sciences Company Information
13.8.2 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
13.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Gilead Sciences Main Business Overview
13.8.5 Gilead Sciences Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-alcoholic Steatohepatitis (NASH) Biomarkers Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Serum Biomarkers
Table 4. Major Players of Cytokeratin-18 (CK 18) Marker
Table 5. Major Players of Inflammatory Markers
Table 6. Major Players of Others
Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023) & (K Units)
Table 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
Table 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2018-2023) & ($ million)
Table 10. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2018-2023)
Table 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023) & (K Units)
Table 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)
Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2018-2023)
Table 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2018-2023)
Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2018-2023) & (K Units)
Table 18. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company (2018-2023)
Table 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company (2018-2023)
Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Producing Area Distribution and Sales Area
Table 23. Players Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
Table 24. Non-alcoholic Steatohepatitis (NASH) Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Geographic Region (2018-2023)
Table 29. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country/Region (2018-2023)
Table 33. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)
Table 36. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2023)
Table 37. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2023)
Table 39. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023) & (K Units)
Table 40. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023) & (K Units)
Table 41. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2018-2023) & (K Units)
Table 42. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2018-2023)
Table 43. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2018-2023)
Table 45. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023) & (K Units)
Table 46. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023) & (K Units)
Table 47. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)
Table 48. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2023)
Table 49. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2023)
Table 51. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023) & (K Units)
Table 52. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Table 60. Key Market Challenges & Risks of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Table 61. Key Industry Trends of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Table 62. Non-alcoholic Steatohepatitis (NASH) Biomarkers Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
Table 65. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customer List
Table 66. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Biopredictive Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 81. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 82. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Biopredictive Main Business
Table 84. Biopredictive Latest Developments
Table 85. Quest Diagnostics Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 86. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 87. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Quest Diagnostics Main Business
Table 89. Quest Diagnostics Latest Developments
Table 90. Exalenz Bioscience Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 91. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 92. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Exalenz Bioscience Main Business
Table 94. Exalenz Bioscience Latest Developments
Table 95. GENFIT Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 96. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 97. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. GENFIT Main Business
Table 99. GENFIT Latest Developments
Table 100. Siemens Healthineers Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 101. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 102. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Siemens Healthineers Main Business
Table 104. Siemens Healthineers Latest Developments
Table 105. ONE WAY LIVER Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 106. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 107. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. ONE WAY LIVER Main Business
Table 109. ONE WAY LIVER Latest Developments
Table 110. Prometheus Laboratories Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 111. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 112. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Prometheus Laboratories Main Business
Table 114. Prometheus Laboratories Latest Developments
Table 115. Gilead Sciences Basic Information, Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 116. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolios and Specifications
Table 117. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Gilead Sciences Main Business
Table 119. Gilead Sciences Latest Developments
List of Figures
Figure 1. Picture of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 2. Non-alcoholic Steatohepatitis (NASH) Biomarkers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Serum Biomarkers
Figure 10. Product Picture of Cytokeratin-18 (CK 18) Marker
Figure 11. Product Picture of Inflammatory Markers
Figure 12. Product Picture of Others
Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type in 2022
Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2018-2023)
Figure 15. Non-alcoholic Steatohepatitis (NASH) Biomarkers Consumed in Hospitals
Figure 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Hospitals (2018-2023) & (K Units)
Figure 17. Non-alcoholic Steatohepatitis (NASH) Biomarkers Consumed in Diagnostic Centers
Figure 18. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Diagnostic Centers (2018-2023) & (K Units)
Figure 19. Non-alcoholic Steatohepatitis (NASH) Biomarkers Consumed in Others
Figure 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Others (2018-2023) & (K Units)
Figure 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2022)
Figure 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application in 2022
Figure 23. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market by Company in 2022 (K Units)
Figure 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Company in 2022
Figure 25. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Company in 2022
Figure 27. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2018-2023 (K Units)
Figure 30. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2018-2023 ($ Millions)
Figure 31. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2018-2023 (K Units)
Figure 32. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2018-2023 ($ Millions)
Figure 33. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2018-2023 (K Units)
Figure 34. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2018-2023 ($ Millions)
Figure 37. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country in 2022
Figure 38. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country in 2022
Figure 39. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
Figure 40. Americas Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)
Figure 41. United States Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region in 2022
Figure 46. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Regions in 2022
Figure 47. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
Figure 48. APAC Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)
Figure 49. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country in 2022
Figure 57. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country in 2022
Figure 58. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
Figure 59. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)
Figure 60. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)
Figure 69. Egypt Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers in 2022
Figure 75. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 76. Industry Chain Structure of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 77. Channels of Distribution
Figure 78. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Forecast by Region (2024-2029)
Figure 79. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の非アルコール性脂肪肝炎（NASH）バイオマーカー市場予測 2023年-2029年(Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場2022：血清バイオマーカー、肝線維症バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆